On October 28th, 2021, PMPRB provided their first update to the Notice & Comment that was issued on July 15, 2021.
The primary takeaway is PMPRB will be providing patentees two reporting periods for compliance, a change from PMPRB's earlier position expecting one reporting period for ... Read More
Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022. A discussion paper summarizing the Advisory Panel’s interim recommendations and proposed process will be posted on the CADTH website and CADTH will host an information session on January 18, 2022 at 1 p.m. (ET). ... Read More
On December 16, 2021, CADTH provided an update regarding CADTH’s drug review programs.
A. Expanded Provisional Funding Algorithm Process
CADTH has expanded the provisional funding algorithm process to include a new rapid algorithm process. This rapid algorithm process will be ... Read More
In cancer care, patients often face increased anxiety and uncertainty about their future care pathway. This is paired with an immediate need for therapy to treat potentially aggressive disease.
Coverage eligibility for THCD varies significantly across Canadian provinces, creating interprovincial differences. Gaps in coverage of THCDs across provinces lead to inequitable ... Read More
PDCI Welcomes Véronique Scott & Ishan Kumar to the Team
Ishan Kumar joins PDCI
as Manager, Data Innovation and Insights. As a member of PDCI’s data insights
team, Ishan’s role includes designing ... Read More
PMPRB: Federal Court of Appeal quashes PMPRB Alexion / Soliris Decision with Significant Implications for the New PMPRB Guidelines
In a unanimous July 29 decision, the Federal Court of Appeal (FCA) overturned a Federal Court judicial review and quashed the PMPRB decision in ... Read More
Deadline Extended: PMPRB Notice and Comment - New Price Tests for Grandfathered Medicines
On July 15th, 2021, the PMPRB invited stakeholders to comment on three amendments to the regulations with responses due by August 15th 2021. PMPRB announced today that the deadline has been ... Read More
PDCI Market Access has further expanded its Market Access Team!
Jessica joins PDCI as Manager, Market Access. She will be responsible for coordinating our pricing and market access projects including HTA and payer ... Read More